Cargando…

Measuring longitudinal cognition: Individual tests versus composites

INTRODUCTION: Longitudinal cohort studies of cognitive aging must confront several sources of within-person variability in scores. In this article, we compare several neuropsychological measures in terms of longitudinal error variance and relationships with biomarker-assessed brain amyloidosis (Aβ)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonaitis, Erin M., Koscik, Rebecca L., Clark, Lindsay R., Ma, Yue, Betthauser, Tobey J., Berman, Sara E., Allison, Samantha L., Mueller, Kimberly D., Hermann, Bruce P., Van Hulle, Carol A., Christian, Bradley T., Bendlin, Barbara B., Blennow, Kaj, Zetterberg, Henrik, Carlsson, Cynthia M., Asthana, Sanjay, Johnson, Sterling C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Cognitive & Behavioral Assessment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816509/ https://www.ncbi.nlm.nih.gov/pubmed/31673596 http://dx.doi.org/10.1016/j.dadm.2018.11.006

Ejemplares similares

Amyloid beta associations with connected speech in cognitively unimpaired adults
por: Mueller, Kimberly D., et al.
Publicado: (2021)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease
por: Vesperman, Clayton J., et al.
Publicado: (2022)

Cardiorespiratory fitness mitigates brain atrophy and cognitive decline in adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2021)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023)

Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers
por: Jonaitis, Erin M., et al.
Publicado: (2022)

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease
por: Law, Lena L., et al.
Publicado: (2018)

A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium
por: Gross, Alden L., et al.
Publicado: (2017)

Comparison of “Word” vs. “Picture” version of the Free and Cued Selective Reminding Test (FCSRT) in older adults
por: Zimmerman, Molly E., et al.
Publicado: (2015)

Automated semantic relevance as an indicator of cognitive decline: Out‐of‐sample validation on a large‐scale longitudinal dataset
por: Stegmann, Gabriela, et al.
Publicado: (2022)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
por: Allison, Samantha L., et al.
Publicado: (2019)

A quadratic function of activation in individuals at risk of Alzheimer's disease
por: Corriveau‐Lecavalier, Nick, et al.
Publicado: (2021)

An approach to classifying subjective cognitive decline in community‐dwelling elders
por: Rabin, Laura A., et al.
Publicado: (2020)

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
por: Erickson, Pontus, et al.
Publicado: (2023)

T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples
por: Katz, Mindy J., et al.
Publicado: (2021)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia
por: Giraldo, Diana L., et al.
Publicado: (2021)

Concordance of the Montreal cognitive assessment with standard neuropsychological measures
por: Vogel, Sally J., et al.
Publicado: (2015)

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score
por: Lim, Yen Ying, et al.
Publicado: (2015)

Physiological phenotyping of dementias using emotional sounds
por: Fletcher, Phillip D., et al.
Publicado: (2015)

Development of a subjective cognitive decline questionnaire using item response theory: A pilot study
por: Gifford, Katherine A., et al.
Publicado: (2015)

Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping
por: McGuinness, Bernadette, et al.
Publicado: (2015)

Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness
por: Harrington, Karra D., et al.
Publicado: (2017)

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
por: Insel, Philip S., et al.
Publicado: (2016)

Further education improves cognitive reserve and triggers improvement in selective cognitive functions in older adults: The Tasmanian Healthy Brain Project
por: Thow, Megan E., et al.
Publicado: (2017)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
por: Buckley, Rachel F., et al.
Publicado: (2019)

Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests
por: Rahman‐Filipiak, Annalise, et al.
Publicado: (2022)

BHA‐CS: A novel cognitive composite for Alzheimer's disease and related disorders
por: Tsoy, Elena, et al.
Publicado: (2020)

A computerized, self-administered test of verbal episodic memory in elderly patients with mild cognitive impairment and healthy participants: A randomized, crossover, validation study
por: Morrison, Randall L., et al.
Publicado: (2018)

Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis
por: Baker, Jenalle E., et al.
Publicado: (2016)

Development and assessment of a brief screening tool for psychosis in dementia
por: Cummings, Jeffrey L., et al.
Publicado: (2021)

Uniform data set language measures for bvFTD and PPA diagnosis and monitoring
por: Staffaroni, Adam M., et al.
Publicado: (2021)

Evidence for age-associated cognitive decline from Internet game scores
por: Geyer, Jason, et al.
Publicado: (2015)

Machine learning approaches to predicting amyloid status using data from an online research and recruitment registry: The Brain Health Registry
por: Albright, Jack, et al.
Publicado: (2021)

Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia
por: Hackett, Katherine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s61fle90ho5qpv30feegou9dhl